In the apoE-/- mouse model of atherosclerosis, TPTS/C/T exhibited good synergistic therapy, anti-atherosclerosis effects, and biosafety by targeting the release of simvastatin and ticagrelor in plaques 50. Here, APOE is linked to atherosclerosis.